| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9968553 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(8 years from now) | |
| US9855214 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(8 years from now) | |
| US8568747 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(8 years from now) | |
| US8778366 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(8 years from now) | |
Epaned Kit is owned by Silvergate Pharms.
Epaned Kit contains Enalapril Maleate.
Epaned Kit has a total of 4 drug patents out of which 0 drug patents have expired.
Epaned Kit was authorised for market use on 13 August, 2013.
Epaned Kit is available in for solution;oral dosage forms.
Epaned Kit can be used as method of treating left ventricular dysfunction, treatment of heart failure.
The generics of Epaned Kit are possible to be released after 06 November, 2032.
Drugs and Companies using ENALAPRIL MALEATE ingredient
Market Authorisation Date: 13 August, 2013
Treatment: Treatment of heart failure; Method of treating left ventricular dysfunction
Dosage: FOR SOLUTION;ORAL
EPANED KIT family patents
